1 |
Li W, Wang H, Xu XG, Yu Y. Simultaneous Nanoscale Imaging of Chemical and Architectural Heterogeneity on Yeast Cell Wall Particles. Langmuir 2020;36:6169-77. [PMID: 32419466 DOI: 10.1021/acs.langmuir.0c00627] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
2 |
Miao J, Ye S, Lan J, Ye P, Wen Q, Mei L, Liu X, Lin J, Zhou X, Du S, Liu X, Li H. Nuclear HMGB1 promotes the phagocytic ability of macrophages. Exp Cell Res 2020;393:112037. [PMID: 32360192 DOI: 10.1016/j.yexcr.2020.112037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Costa LM, Muálem de Moraes Alves M, Brito LM, de Araujo Abi-Chacra E, Barbosa-Filho JM, Chavez Gutierrez SJ, Barreto HM, Aécio de Amorim Carvalho F. In vitro antileishmanial and immunomodulatory activities of the synthetic analogue riparin E. Chem Biol Interact 2021;336:109389. [PMID: 33484715 DOI: 10.1016/j.cbi.2021.109389] [Reference Citation Analysis]
|
4 |
Abraham A, Ostroff G, Levitz SM, Oyston PCF. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Clin Exp Immunol 2019;198:143-52. [PMID: 31400225 DOI: 10.1111/cei.13356] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
5 |
Tokuhara D, Hikita N. Cord Blood-Based Approach to Assess Candidate Vaccine Adjuvants Designed for Neonates and Infants. Vaccines (Basel) 2021;9:95. [PMID: 33514054 DOI: 10.3390/vaccines9020095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|